The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
grants from the National Institutes of Health, Department of Defense, etc to perform basic and/or translational research on all themes of cardiovascular biology and medicine, including but not limited
-
enthusiastic postdoctoral scientist to join Prof Mauro Giacca’s laboratory at the School of Cardiovascular and Metabolic Medicine & Sciences at King's College London. The postholder will be part of a vibrant
-
pharmaceutical sponsored clinical trials. We collaborate with Department of Pediatrics, the Department of Surgery, and the Department of Cardiovascular Sciences within the Brody School of Medicine. The Department
-
clinical area related to research in the School of Cardiovascular and Metabolic Health (e.g. cardiology, renal medicine, clinical pharmacology, chemical pathology, diabetes and endocrinology, at least ST3
-
Biomedical Sciences, Pharmacology and Toxicology Concentration, is broadly based to prepare students for careers in academics, research, government, industry, and medicine. State-of-the-art facilities support
-
of patients, populations and communities through excellence in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and
-
role contributing to research in cardiovascular disease prevention and management Level A/B Salary $ 79,784 - $ 134, 403 + 17% superannuation About the opportunity The Sydney School of Health Sciences
-
Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can
-
of Medicine with over 26 Divisions, Programs and Centers/Institutes. The Department's ongoing growth includes the restructure of Cardiovascular Sciences from a separate Department to a Division, support of the
-
, research accumulated over the past two decades underscores the crucial role of disrupted oral and gut microbiota in the onset and progression of various conditions, including cardiovascular disease, type 2